These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 19850204)

  • 1. The adrenergic-fatty acid load in heart failure.
    Opie LH; Knuuti J
    J Am Coll Cardiol; 2009 Oct; 54(18):1637-46. PubMed ID: 19850204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy.
    Tuunanen H; Engblom E; Naum A; Någren K; Scheinin M; Hesse B; Juhani Airaksinen KE; Nuutila P; Iozzo P; Ukkonen H; Opie LH; Knuuti J
    Circulation; 2008 Sep; 118(12):1250-8. PubMed ID: 18765391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic modulation: a new therapeutic target in treatment of heart failure.
    Palaniswamy C; Mellana WM; Selvaraj DR; Mohan D
    Am J Ther; 2011 Nov; 18(6):e197-201. PubMed ID: 20393344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Catecholamines and beta-blockers in heart failure: some physiopathological and pharmacological reflections].
    Pasini E; Opasich C; Aquilani R
    Ital Heart J Suppl; 2000 Feb; 1(2):171-9. PubMed ID: 10731374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic manipulation in ischaemic heart disease, a novel approach to treatment.
    Lee L; Horowitz J; Frenneaux M
    Eur Heart J; 2004 Apr; 25(8):634-41. PubMed ID: 15084367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of free fatty acids metabolism as a therapeutic target in patients with heart failure.
    Fragasso G
    Int J Clin Pract; 2007 Apr; 61(4):603-10. PubMed ID: 17394434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of heart failure with insulin resistance and the development of type 2 diabetes.
    Kostis JB; Sanders M
    Am J Hypertens; 2005 May; 18(5 Pt 1):731-7. PubMed ID: 15882558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation in chronic heart failure.
    Parish RC; Evans JD
    Ann Pharmacother; 2008 Jul; 42(7):1002-16. PubMed ID: 18477736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of diet and fuel overabundance in the development and progression of heart failure.
    Chess DJ; Stanley WC
    Cardiovasc Res; 2008 Jul; 79(2):269-78. PubMed ID: 18343896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saturated fatty acid-induced insulin resistance is associated with mitochondrial dysfunction in skeletal muscle cells.
    Hirabara SM; Curi R; Maechler P
    J Cell Physiol; 2010 Jan; 222(1):187-94. PubMed ID: 19780047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic therapy for heart failure.
    Essop MF; Opie LH
    Eur Heart J; 2004 Oct; 25(20):1765-8. PubMed ID: 15474689
    [No Abstract]   [Full Text] [Related]  

  • 12. Optimizing cardiac fatty acid and glucose metabolism as an approach to treating heart failure.
    Lopaschuk GD
    Semin Cardiothorac Vasc Anesth; 2006 Sep; 10(3):228-30. PubMed ID: 16959756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic mechanisms in heart failure.
    Ashrafian H; Frenneaux MP; Opie LH
    Circulation; 2007 Jul; 116(4):434-48. PubMed ID: 17646594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting malonyl CoA inhibition of mitochondrial fatty acid uptake as an approach to treat cardiac ischemia/reperfusion.
    Ussher JR; Lopaschuk GD
    Basic Res Cardiol; 2009 Mar; 104(2):203-10. PubMed ID: 19242641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of free fatty acid-induced hepatic lipotoxicity in HepG2 cells by magnesium isoglycyrrhizinate in vitro.
    Cheng Y; Zhang J; Shang J; Zhang L
    Pharmacology; 2009; 84(3):183-90. PubMed ID: 19752584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic remodelling of the failing heart: beneficial or detrimental?
    van Bilsen M; van Nieuwenhoven FA; van der Vusse GJ
    Cardiovasc Res; 2009 Feb; 81(3):420-8. PubMed ID: 18854380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resting heart rate does not reflect the degree of beta-blockade in subjects with heart failure on chronic beta-blocker therapy.
    Mignatti A; Sims DB; Colombo PC; Garcia LI; Bijou R; Deng MC; Jorde UP
    Cardiovasc Ther; 2009; 27(1):42-8. PubMed ID: 19207479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metabolic effect of glucagon in chronic cardiac insufficiency].
    Franke F; Berchthold P; Simon H
    Med Welt; 1972 Oct; 23(41):1421-3. PubMed ID: 5087189
    [No Abstract]   [Full Text] [Related]  

  • 19. Targeting mitochondrial oxidative metabolism as an approach to treat heart failure.
    Fillmore N; Lopaschuk GD
    Biochim Biophys Acta; 2013 Apr; 1833(4):857-65. PubMed ID: 22960640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of the senescent heart to stress: clinical therapeutic strategies and quest for mitochondrial predictors of biological age.
    Rosenfeldt F; Miller F; Nagley P; Hadj A; Marasco S; Quick D; Sheeran F; Wowk M; Pepe S
    Ann N Y Acad Sci; 2004 Jun; 1019():78-84. PubMed ID: 15246998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.